Abstract:Sixteen Co(II), Ni(II), Cu(II) and Zn(II) complexes were synthesized by four Schiff base ligands 4-((4-(benzyloxy)-2-hydroxybenzylidene)amino)-[1,1'-biphenyl]-3-ol (H2L1), 6-((4-(benzyloxy)-2-hydroxybenzylidene)amino)-4,6-dichloro-3-methylphenol (H2L2), 2-((4-(benzyloxy)-2-hydroxybenzylidene)amino)-6-chloro-4-nitrophenol (H2L3), 5-(benzyloxy)-2-(((2-hydroxyphenyl)imino)methyl)phenol (H2L4) obtained from condensation reaction of 4-(benzyloxy)-2-hydroxybenzaldehyde with various aminophenol derivatives and well characterized by various spectroscopic techniques (FT-IR, UV–Vis, NMR, ESR, SEM, fluorescence), mass spectrometry, elemental analysis (CHN) and physical studies (TGA, XRD, molar conductance, melting point). The various characterization data suggested that the Schiff base ligands coordinated via nitrogen of azomethine and deprotonated phenolic oxygen atoms (ONO) with metal ions in 1:1 molar ratio having general formula [M(L1−4)(H2O)2(CH3COO)]. Low values of molar conductance of compounds suggested their non-electrolytic nature. The thermal decomposition of complexes indicated that metal complexes are stable up to 150 °C and give metal oxide as end product. Using SEM analysis, the surface morphology of the synthesized compound was determined. The compounds (1–20) were evaluated for their in vitro antioxidant activity and found that the synthesized metal(II) complexes are highly potent and also show good efficiency for decolourizing the purple-coloured solution of DPPH compared to free Schiff base ligands and Cu(II) complexes were most potent having IC50 value from 2.98 to 3.89 µM range. The compounds (1–20) were assayed for their in vitro antimicrobial activities against four bacterial strains (S. aureus, B. subtilis, P. aeruginosa, E. coli) and two fungal strains (A. niger, C. albicans) by serial dilution method, and it was found that the metal(II) complexes are more noxious than free Schiff base ligands. The antimicrobial activity results showed that the complexes 10, 11, 14 and 15 were most active compounds. Antifungal activity of complex 11 (Cu(L2)(CH3COO)(H2O) against C. albicans was found to be comparable to standard drug. The molecular docking of ligand H2L2 (2) and its Cu(II) complex (11) with enzyme C. albicans sterol 14-alpha demethylase suggested the hydrophobic binding. Furthermore, in silico study stressed that the compounds may be used as orally active drugs.Graphical abstractThe synthesized compounds (1–20) were screened for in vitro antimicrobial activity. Copper complex (11) was found to be the most potent antimicrobial agent and which is held by hydrophobic interactions in the active site of the enzyme C. albicans sterol 14-alpha demethylase.

Structural, catalytic, antimicrobial and antioxidant properties of Cu(II)-complexes prepared by o-hydroxy Schiff bases with fluorine and ethoxy substituents

Synthesis, spectro-themal characterization, DFT calculations and biochemical evaluation of a newly synthesized tridentate Schiff base transition metal complexes

Synthesis, Characterization, Crystal Structure and Antimicrobial Activity of Copper(II) Complexes with the Schiff Base Derived from 2-Hydroxy-4-Methoxybenzaldehyde

Synthesis, catalysis, antimicrobial activity, and DNA interactions of new Cu(II)-Schiff base complexes

Copper(ii) complexes of sterically hindered phenolic Schiff bases: synthesis, characterization, interaction with biomolecules, and antioxidant and antimicrobial activity

Synthesis, structural characterization, antioxidant, cytotoxic activities and docking studies of schiff base Cu(II) complexes

Synthesis, spectroscopic characterization, density functional theory calculations and biological evaluation of novel Cu(II) and Zn(II) Schiff base complexes as antimicrobial agents

Synthesis, Crystal Structures, Photophysical Properties and Antibacterial Activities of Copper(II) Complex Derived from 4-Chloro-2-{[(2,6-dimethylphenyl)imino]methyl}phenol

Synthesis, structural analysis, in vitro antioxidant, antimicrobial activity and molecular docking studies of transition metal complexes derived from Schiff base ligands of 4-(benzyloxy)-2-hydroxybenzaldehyde

Copper(II)-photocatalyzed Hydrocarboxylation of Schiff bases with CO2: antimicrobial evaluation and in silico studies of Schiff bases and unnatural α-amino acids

Novel Co(II), Cu(II) and Fe(II) Pentadentate Schiff base complexes: Synthesis, characterization, antimicrobial, antioxidant, and molecular docking studies

SYNTHESIS, CHARACTRIZATION AND ANTIBACTERIAL ACTIVITY OF SCHIFF BASES DERIVED FROM PHENYL HYDRAZINE DERIVATIVES AND THEIR Cu (II) and Zn (II) COMPLEXES

Synthesis, Characterization, Antioxidant and Antimicrobial Activities of A Bidentate Schiff Base Ligand and Its Metal Complexes

Nickel(II), copper(II) and zinc(II) complexes containing symmetrical Tetradentate Schiff base ligand derived from 3,5-diiodosalicylaldehyde: Synthesis, characterization, crystal structure and antimicrobial activity

Investigation of the inherent characteristics of copper(II) Schiff base complexes as antimicrobial agents

Syntheses, Crystal Structures and Antibacterial Activities of Copper(Ii) and Zinc(Ii) Complexes Based on (E)-4-fluoro-2-((3-morpholinopropylimino)methyl)phenol

Anion Induced Synthesis and Crystal Structures of Schiff Base Copper(II) and Zinc(II) Complexes with Antibacterial Activity

SYNTHESIS, CHARACTERIZATION AND ANTIMICROBIAL ACTIVITIES OF Ni(II) AND Cu(II) COMPLEXES WITH SCHIFF BASE DERIVED FROM 2-ACETYL-5-METHYLFURAN GLYOXIME HYDRAZONE

Synthesis, Structural and Antimicrobial Studies of Transition Metal Complexes of a Novel Schiff Base Ligand Incorporating 1,2,4-Triazole and 4-(Benzyloxy)benzaldehyde Moieties

Studies on the antibacterial and catalytic activity of Schiff base mono-and di-nuclear complexes

Coordinated metal complexes with curcumin Schiff base: Synthesis, investigation, antibacterial screening, antioxidant studies, molecular docking and density function theory calculations